Results 241 to 250 of about 1,459,532 (261)
Some of the next articles are maybe not open access.
The future of CFTR modulating therapies for cystic fibrosis
Current Opinion in Pulmonary Medicine, 2015Huge progress has been made over the last few years in the field of small molecule therapies targeting cystic fibrosis transmembrane conductance regulator (CFTR), the protein defective in patients with cystic fibrosis. This review describes the progress and areas of future research.Ivacaftor is the first drug of its kind to be licensed for clinical use
openaire +2 more sources
Keeping up with CFTR modulator eligibility.
Paediatric Respiratory ReviewsThe availability of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators has transformed outcomes for people with cystic fibrosis (pwCF).
Rebecca Jackson +3 more
semanticscholar +1 more source
Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis
International Journal of Molecular Sciences, 2023Simon Y Graeber +2 more
exaly
PULMONOLOGY: CFTR modulators for cystic fibrosis
Journal of the American Academy of Physician Assistants, 2013Erica, Bertoncini, Dawn, Colomb-Lippa
openaire +2 more sources
CFTR modulator drug desensitization: Preserving the hope of long term improvement
Pediatric Pulmonology, 2021Kelsey Leonhardt +2 more
exaly
Reducing treatment burden in the era of CFTR modulators
The Lancet Respiratory Medicine, 2023Robinson, Paul D. +2 more
openaire +4 more sources
Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era
Journal of Personalized Medicine, 2021Raksha Jain +2 more
exaly
Simplifying CFTR modulation therapy in cystic fibrosis
Archives of Disease in Childhood, 2023openaire +2 more sources
Impact of novel CFTR modulator on sinonasal quality of life in adult patients with cystic fibrosis
International Forum of Allergy and Rhinology, 2021Jennifer E Douglas +2 more
exaly